Leaps by Bayer logo

Leaps by Bayer

Europe, Nordrhein-Westfalen, Germany, Leverkusen

Description

Leaps by Bayer invests in life sciences and specializes in the fields of biotechnology, agriculture, and scientific breakthrough.

Investor Profile

Leaps by Bayer has made 105 investments, with 11 in the past 12 months and 41% as lead.

Stage Focus

  • Series A (38%)
  • Series B (30%)
  • Series C (10%)
  • Series D (8%)
  • Series Unknown (8%)
  • Seed (4%)
  • Post Ipo Equity (2%)
  • Corporate Round (1%)
  • Convertible Note (1%)

Country Focus

  • United States (86%)
  • Canada (6%)
  • United Kingdom (3%)
  • Kenya (2%)
  • Germany (1%)
  • Singapore (1%)
  • China (1%)
  • Brazil (1%)

Industry Focus

  • Biotechnology
  • Health Care
  • Agriculture
  • Therapeutics
  • Medical
  • Life Science
  • Agtech
  • Biopharma
  • Artificial Intelligence (Ai)
  • Machine Learning
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Leaps by Bayer frequently co-invest with?

Fall Line Capital
North America, California, United States, San Mateo
Co-Investments: 6
Alexandria Venture Investments
North America, California, United States, Pasadena
Co-Investments: 14
Catalio Capital Management
North America, New York, United States, New York
Co-Investments: 6
Agent Capital
North America, Massachusetts, United States, Cambridge
Co-Investments: 5
S2G Ventures
North America, Illinois, United States, Chicago
Co-Investments: 8
RA Capital Management
North America, Massachusetts, United States, Boston
Co-Investments: 9
7wire Ventures
North America, Illinois, United States, Chicago
Co-Investments: 8
Polaris Partners
North America, Massachusetts, United States, Boston
Co-Investments: 12
Sanofi Ventures
North America, Massachusetts, United States, Cambridge
Co-Investments: 6
ARCH Venture Partners
North America, Illinois, United States, Chicago
Co-Investments: 11

Which angels does Leaps by Bayer often collaborate with?

GF
North America, California, United States
Shared Deals: 2
JM
North America, United States
Shared Deals: 1
MB
North America, California, United States, San Francisco
Shared Deals: 1
NA
North America, California, United States, San Francisco
Shared Deals: 1
MD
Europe, Bayern, Germany, Erlangen
Shared Deals: 1

What are some of recent deals done by Leaps by Bayer?

Indapta Therapeutics

San Francisco, California, United States

Indapta Therapeutics is a privately held biotechnology company.

BiopharmaBiotechnologyMedical
Series UnknownDec 17, 2024
Amount Raised: $22,500,000
one.bio

Sacramento, California, United States

one.bio is an emerging biotechnology spinout from UC Davis that creates ingredients for food and biopharmaceutical applications.

BiotechnologyFood and BeverageHealth Care
Series ADec 12, 2024
Amount Raised: $27,000,000
Nuvig Therapeutics

Redwood City, California, United States

Nuvig Therapeutics is a biotechnology company developing therapies to induce natural mechanisms to restore immune homeostasis.

BiotechnologyHealth CareTherapeutics
Series BDec 5, 2024
Amount Raised: $161,000,000
Senti Biosciences

South San Francisco, California, United States

Senti Biosciences is a biotechnology company that focuses on synthetic biology and gene circuit engineering for therapeutic applications.

BiotechnologyHealth CareMedicalTherapeutics
Post Ipo EquityDec 2, 2024
Amount Raised: $47,600,000
EarthOptics

Arlington, Virginia, United States

EarthOptics provides a cloud-based machine learning platform for soil and ground management.

AgricultureAgTechInformation TechnologyReal Time
Series UnknownNov 19, 2024
Amount Raised: $24,000,000
Pairwise Plants

Durham, North Carolina, United States

Pairwise is a purpose-driven food+tech company dedicated to building a healthier world through better fruits and vegetables.

AgricultureFood and Beverage
Series CSep 17, 2024
Amount Raised: $40,000,000
EGenesis

Cambridge, Massachusetts, United States

EGenesis is a gene editing and genome engineering company developing human-compatible engineered organs to treat diseases.

BiopharmaBiotechnologyGeneticsLife ScienceMedical
Series DSep 4, 2024
Amount Raised: $191,000,000
GRO Biosciences

Boston, Massachusetts, United States

GRO Biosciences is a biotechnology company that develops a protein therapeutics technology to improve treatments across multiple diseases.

BiotechnologyHealth DiagnosticsMedicalPharmaceuticalTherapeutics
Series BJul 19, 2024
Amount Raised: $60,300,000
Huma

London, England, United Kingdom

Huma offers a health platform used for remote patient monitoring and biological data gathering for preventative healthcare.

Artificial Intelligence (AI)Health CaremHealthSaaS
Series DJul 16, 2024
Amount Raised: $80,000,000
Transcarent

Denver, Colorado, United States

Transcarent is a provider of a healthcare platform that facilitates improved outcomes and cost-effective decisions.

Health CarePersonal HealthSoftware
Series DMay 2, 2024
Amount Raised: $126,000,000